Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Law Bytes Podcast, Episode 273: Rebroadcast of the Globe and Mail’s The Decibel on Canada’s First Steps Towards a Social Media Ban 
Midnight Madness: The Government Rushes Lawful Access Bill Through the House Without Debate or a Recorded Vote 
One Step Forward, Two Steps Back: Bill C-36 Modernizes Canada’s Privacy Law, Then Delays It to 2030 
Gary Anandasangaree’s Vic Toews Moment Shows the Government Has Lost Its Way on Lawful Access 
Government Moves to Shut Down Lawful Access Hearing In Order To Fast Track Passing the Bill This Week
